Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
QEP Resources Reports First Quarter 2017 Financial and Operating Results
-
Argus Downgrades T. Rowe Price (TROW) to Hold
-
ARGUS Successfully Implements TCS' ACUITY Advanced Care™
-
Illinois Tool Works (ITW) PT Raised to $160 at Argus
-
Second Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call
-
Valero Energy Reports First Quarter 2017 Results
-
UPDATE: Argus Upgrades Travelers (TRV) to Buy
-
Argus Downgrades Verizon Communications (VZ) to Hold
-
Argus Cyber Security Solutions Shortlisted for 2017 TU-Automotive Awards for Third Consecutive Year
-
Argus Upgrades ADTRAN (ADTN) to Buy
-
Okayama University Research: Successful Test of Retinal Prosthesis Implanted in Rats
-
Private Jet Charter Company Latitude 33 Aviation Achieves Prestigious ARGUS Platinum Rating
-
Argus Starts Central Garden & Pet Co. (CENT) at Buy
-
UPDATE: Argus Upgrades Fastenal (FAST) to Buy
-
Pre-Open Movers 04/13: (OCRX) (EYES) (AAOI) Higher; (SRNE) (DMPI) (PIR) Lower (more...)
-
Argus Cyber Security Working With Bosch to Promote Public Safety and Mitigate Car Hacking
-
Second Sight Medical (EYES) Gains 25% Pre-Market on Positive Argus II News
-
Second Sight Medical (EYES) Announces Argus II Implanted in First Patient in Asia
-
Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
-
USC Roski Eye Institute's Amir H. Kashani named to The Ophthalmologist 'Rising Stars' Power List 2017
-
Display Week Promises To Immerse Attendees In The Exciting World Of Augmented And Virtual Reality
-
Exclusive: OPEC figures show oil output cuts exceed pledge in March - sources
-
Form 13F-HR ARGUS INVESTORS' COUNSEL For: Mar 31
-
AUVSI XPONENTIAL 2017 Hosts Co-Located Events Focusing on Repair, UAS Research, Safety and Civilian Applications
-
NCPDP Announces Newly Elected Board of Trustees and Special Events at its 40th Anniversary Conference
-
Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow
-
Argus Starts Sanofi (SNY) at Buy, $50 PT
-
Argus Upgrades Wynn Resorts (WYNN) to Buy
-
Porsche Vehicles Are Now Available to Add Luxury, Comfort to the Experience of Delta Private Jets Customers
-
Argus Downgrades Nike (NKE) to Hold
-
Bayou City Raises Approximately $1.0 Billion in Two Years for E&P Investments; Closes Second Fund at $310 Million Hard Cap
-
Argus Starts Snap Inc (SNAP) at Hold
-
Argus Radiology Licenses and Expands Their Personalized Version of TeleRadiology into Indiana
-
Reolink Argus Wire-Free Camera Crowdfunding Campaign Launches on Indiegogo
-
PogoTec Brings World’s Smallest Attachable Eyewear Camera to Vision Expo East
-
UPDATE: Argus Starts Bioverativ Inc (BIVV) at Hold
-
Form 24F-2NT Smart Trust, Argus Divid For: Dec 31
-
Form 24F-2NT Smart Trust, Argus Divid For: Dec 31
-
Form 24F-2NT Smart Trust, Argus Divid For: Dec 31
-
Form 24F-2NT Smart Trust, Argus Divid For: Dec 31
-
Form 24F-2NT Smart Trust, Argus Selec For: Dec 31
-
Second Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol “EYESW”
-
UPDATE: Argus Downgrades International Game Tech (IGT) to Hold
-
Argus Starts Tesaro (TSRO) at Buy, "Strong prospects in immuno-oncology"
-
Mobileye deal to fuel investment in late-stage Israeli start-ups
-
Altus Group Delivers Greater Decision-Making Horsepower to Commercial Real Estate Industry with ARGUS Enterprise 11.6
-
Altus Group Delivers Greater Decision-Making Horsepower to Commercial Real Estate Industry with ARGUS Enterprise 11.6
-
Priester Aviation Expands With New King Air 250 in Boston
-
Wells Fargo banks on new ad campaign to regain customer trust
-
JetSuiteX Announces Pop-Up Flights from Burbank/LA to the Coachella Valley in April

